找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Nanotheranostics for Cancer Applications; Prakash Rai,Stephanie A. Morris Book 2019 This is a U.S. government work and not under copyright

[复制链接]
查看: 43412|回复: 57
发表于 2025-3-21 17:16:24 | 显示全部楼层 |阅读模式
书目名称Nanotheranostics for Cancer Applications
编辑Prakash Rai,Stephanie A. Morris
视频video
概述Provides a comprehensive review of cancer nanotheranostics.Represents the first book-length treatment of the topic.Presents a full picture of the field, from basic research through clinical implementa
丛书名称Bioanalysis
图书封面Titlebook: Nanotheranostics for Cancer Applications;  Prakash Rai,Stephanie A. Morris Book 2019 This is a U.S. government work and not under copyright
描述.This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field...Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotelytriggered drug delivery systems to limit cytotoxicity in the diseased area...This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the
出版日期Book 2019
关键词Cancer Diagnostics; Cancer Nanotechnology; Cancer Nanotechnology Case Study; Drug Delivery Cancer; Drug
版次1
doihttps://doi.org/10.1007/978-3-030-01775-0
isbn_ebook978-3-030-01775-0Series ISSN 2364-1118 Series E-ISSN 2364-1126
issn_series 2364-1118
copyrightThis is a U.S. government work and not under copyright protection in the U.S.; foreign copyright pro
The information of publication is updating

书目名称Nanotheranostics for Cancer Applications影响因子(影响力)




书目名称Nanotheranostics for Cancer Applications影响因子(影响力)学科排名




书目名称Nanotheranostics for Cancer Applications网络公开度




书目名称Nanotheranostics for Cancer Applications网络公开度学科排名




书目名称Nanotheranostics for Cancer Applications被引频次




书目名称Nanotheranostics for Cancer Applications被引频次学科排名




书目名称Nanotheranostics for Cancer Applications年度引用




书目名称Nanotheranostics for Cancer Applications年度引用学科排名




书目名称Nanotheranostics for Cancer Applications读者反馈




书目名称Nanotheranostics for Cancer Applications读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:36:13 | 显示全部楼层
Biological Events and Barriers to Effective Delivery of Cancer Therapeuticsractions between tumor cells and their microenvironment. The genetic and epigenetic abnormalities lead to the selective growth of tumor cells that are highly resistant to apoptotic cell death and capable of avoiding immune surveillance. Those aggressive biological characteristics contribute to intri
发表于 2025-3-22 02:48:50 | 显示全部楼层
Cancer Diagnostics and Therapeutics approaches have been initiated and developed resulting in the approval of a significant number of new drugs for the treatment of various cancers and better and improved treatment options, leading to longer survival and better quality of life for the large number of patients diagnosed with the disea
发表于 2025-3-22 06:50:52 | 显示全部楼层
Nanomedicine in Cancerasses of nanoparticles are first described to detail the origin of their useful emergent properties in the context of current needs in cancer medicine and standard clinical practices. Specific applications focus on cancer therapeutics, cancer imaging, and in vitro diagnostics. In particular, this ch
发表于 2025-3-22 11:42:10 | 显示全部楼层
发表于 2025-3-22 15:32:02 | 显示全部楼层
发表于 2025-3-22 18:26:58 | 显示全部楼层
发表于 2025-3-23 00:32:04 | 显示全部楼层
发表于 2025-3-23 05:04:29 | 显示全部楼层
Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulationsl for easily accessible, oral chemotherapy. A growing consensus points to nanoscale drug delivery systems as a promising therapeutic modality with enhanced efficacy and diminished side effects and with increasing evidence that these platforms can be engineered to facilitate transport of poorly bioav
发表于 2025-3-23 05:50:09 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 10:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表